Perrigo | PRGO - Interest Expense On Debt



Perrigo reported 39.6M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
AbbVie USD 700M 90M Mar/2025
Abbott USD 50M 1000K Jun/2025
Bayer 495M 89M Jun/2025
Bristol-Myers Squibb USD 485M 9M Jun/2025
Corcept Therapeutics 6M 6M Jun/2024
Dr.Reddys Laboratories 830M 174M Jun/2025
Eli Lilly USD 249M 5.3M Jun/2025
J&J USD 128M 9M Mar/2025
Merck USD 305M 8M Jun/2025
Nestle 929M 11M Jun/2025
Pacira USD 3.82M 110K Jun/2025
Perrigo 39.6M 600K Jun/2025
Pfizer USD 654M 0 Jun/2025
Prestige Brands USD 10.2M 275K Jun/2025
Reckitt Benckiser 208M 198.3M Dec/2024
Sanofi 148M 65M Jun/2025
Supernus Pharmaceuticals USD 0 0 Dec/2024
Teva Pharmaceutical Industries USD 252M 40M Jun/2025
Xeris Pharmaceuticals USD 7.36M 343K Jun/2025
Zoetis USD 53M 1000K Jun/2025